eClinical Tech News

Profusa has completed its reverse recapitalization with NorthView Acquisition Corporation, cut net debt to approximately $14 million as of...

Novartis has rolled forward its mid-term outlook, guiding to a 5–6% constant-currency sales CAGR for 2025–2030 and lifting peak...

Valneva reported nine-month 2025 revenues of €127.0 million, up 8.9% year over year, with product sales rising 6.2% to...

Protext Mobility has issued a broad corporate update: IFRS-audited 2022 and 2023 financials are complete, 2024 filings are underway...

Tempest Therapeutics is acquiring Factor Bioscience’s dual‑targeting CAR‑T programs in an all‑stock deal that will hand an affiliate of...

Cytomed Therapeutics has completed the acquisition of TCB-002, an allogeneic gamma delta T cell technology from TC BioPharm’s subsidiary,...

Inotiv posted preliminary fourth-quarter fiscal 2025 revenue of $137.5–$138.5 million and full-year revenue of $512.5–$513.5 million, anchored by continued...

Johnson & Johnson has agreed to acquire Halda Therapeutics for $3.05 billion in cash, adding a first-in-class proximity-based small...

Immatics has moved its PRAME franchise into a pivotal phase, with a global, randomized Phase 3 trial (SUPRAME) of...

Nxera Pharma will streamline its operations and refocus R&D around de-risked GPCR biology, cutting approximately 15% of its workforce...